Research Article

ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma

Figure 7

Experimental verification of ARID1A. (a) Immunohistochemical images from the HPA database show ARID1A protein expression in normal live tissues and HCC tissues. (b) Analysis of ARID1A expression in HCC and normal liver cell lines. (c) RT-PCR was used to detect the efficiency of knockdown for ARID1A in 97H. (d) 97H were treated with siRNA against ARID1A for 24 hours and then subjected to the CCK-8 assay. (e) RT-PCR was used to detect the efficiency of knockdown for ARID1A in LM3. (f) LM3 were treated with siRNA against ARID1A for 24 hours and then subjected to the CCK-8 assay. (g–h) 97H and LM3 were treated with siRNA against ARID1A for 24 hours and then subjected to the colony formation assay. , , and .
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)